CATALOGO DEI PRODOTTI DELLA RICERCA

BERTOLDO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.017
EU - Europa 5.695
AS - Asia 4.263
SA - Sud America 735
AF - Africa 70
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.797
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.944
GB - Regno Unito 1.959
SG - Singapore 1.726
CN - Cina 1.483
RU - Federazione Russa 1.026
BR - Brasile 626
IT - Italia 536
SE - Svezia 436
HK - Hong Kong 423
FR - Francia 401
DE - Germania 396
FI - Finlandia 338
IE - Irlanda 321
VN - Vietnam 157
KR - Corea 136
UA - Ucraina 108
TR - Turchia 77
IN - India 46
ID - Indonesia 44
AR - Argentina 37
CA - Canada 36
NL - Olanda 35
JP - Giappone 34
AE - Emirati Arabi Uniti 33
MX - Messico 24
ZA - Sudafrica 20
BD - Bangladesh 17
ES - Italia 17
EC - Ecuador 16
RO - Romania 16
BE - Belgio 15
CL - Cile 15
AT - Austria 13
EE - Estonia 13
CO - Colombia 12
EG - Egitto 12
IR - Iran 12
PL - Polonia 12
CZ - Repubblica Ceca 11
AU - Australia 10
IQ - Iraq 10
VE - Venezuela 10
PK - Pakistan 9
LT - Lituania 8
MA - Marocco 8
MY - Malesia 7
PY - Paraguay 7
SK - Slovacchia (Repubblica Slovacca) 7
IL - Israele 6
PE - Perù 6
DZ - Algeria 5
OM - Oman 5
TG - Togo 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
CR - Costa Rica 4
HU - Ungheria 4
JO - Giordania 4
KE - Kenya 4
UY - Uruguay 4
UZ - Uzbekistan 4
AM - Armenia 3
DK - Danimarca 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
TN - Tunisia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
RS - Serbia 2
SN - Senegal 2
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
Totale 16.783
Salva come PNG Salva come JPEG
Città #
Southend 1.775
Jacksonville 979
Chandler 816
Singapore 752
Dallas 591
Hong Kong 412
Ann Arbor 388
Woodbridge 377
Dublin 318
Houston 316
Ashburn 314
Moscow 202
Beijing 198
Princeton 149
Lawrence 148
Wilmington 137
Nanjing 124
Jinan 109
Verona 109
New York 108
Los Angeles 97
Shenyang 97
Hebei 74
Milan 73
Buffalo 71
Changsha 69
Sindelfingen 69
Helsinki 66
Boardman 64
São Paulo 56
Tianjin 56
Munich 54
Nanchang 53
Redondo Beach 51
Ho Chi Minh City 48
Ningbo 48
Zhengzhou 41
Bologna 39
The Dalles 37
Taizhou 36
Haikou 35
Jiaxing 33
Hangzhou 32
Jakarta 31
Tokyo 31
London 29
Chicago 27
Dearborn 27
San Francisco 27
Santa Clara 27
Columbus 26
Lancaster 24
Hanoi 23
Guangzhou 21
Rio de Janeiro 20
Rome 20
Falls Church 19
Turku 19
Norwalk 18
Fuzhou 17
Dong Ket 16
Seoul 16
Taiyuan 16
Brussels 15
Council Bluffs 15
Detroit 15
Montreal 15
Paris 15
Seattle 15
Johannesburg 13
Lappeenranta 13
Brooklyn 12
Curitiba 12
Redmond 12
Belo Horizonte 11
Falkenstein 11
Mexico City 11
Stockholm 11
Washington 11
Atlanta 10
Brasília 10
Denver 10
Fairfield 10
Frankfurt am Main 10
Lanzhou 10
Nuremberg 10
Phoenix 10
Porto Alegre 10
San Giovanni Lupatoto 10
Boston 9
Florianópolis 9
Toronto 9
Cambridge 8
Orem 8
Warsaw 8
Amsterdam 7
Ankara 7
Auburn Hills 7
Bârlad 7
Dhaka 7
Totale 10.468
Salva come PNG Salva come JPEG
Nome #
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro. 219
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation 205
Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells 196
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 196
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 188
The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells 187
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 184
Adipocytes IGFBP-2 expression in prepubertal obese children. 183
Bone metabolism in patients with anorexia nervosa and amenorrhoea 173
Age-related bone loss in postmenopausal women 171
STEAP mRNA detection in serum of patients with solid tumours. 170
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. 169
BISPHOSPHONATES DECREASE HTERT IN PC3 AND DU-145 PROSTATE CANCER CELLS 165
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 162
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 161
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 160
Incidenza di ipovitaminosi D nel Nord Italia 156
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 152
Bone development during GH and GnRH analog treatment 151
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 151
Histomorphometric analysis of glucocorticoid-induced osteoporosis 150
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: Prednisone versus Deflazacort. 150
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 149
Altered bone metabolism in children infected with human immunodeficiency virus. 145
Blood ionized calcium is associated with clustered polymorphism in the carboxyl-terminal tail of the calcium-sensing receptor. 143
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 140
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020 140
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 139
Guidelines for the diagnosis, prevention and management of osteoporosis 139
The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? 133
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 133
Bone microarchitecture evaluated by histomorphometry 132
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 132
Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panic 131
Bone Microarchitecture in Mild Primary Hyperparathyroidism 130
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 129
ARTROPATIE DISMETABOLICHE 128
Osteopenia induced by immunosuppressive drugs in rats. Histomorphometric analisys of risedronate effects. 127
Bisfosfonati e metastasi ossee:up-to-date 2005 127
The renal handling of calcium: influence of parathyroid hormone secretion 126
GAPDH: CONSTITUTIVE HOUSEKEEPING GENE OR TARGET FOR THERAPEUTIC INTERVENTION? 126
Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. 123
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation 122
Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. 122
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 120
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 120
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) 120
Incidenza di ipovitaminosi D nel Nord Italia 119
Drug-induced osteonecrosis of the jaw: the state of the art 119
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 118
Artropatie dismetaboliche 117
PEAK BONE MASS AND BODY COMPOSITION IN PRECOCIOUS PUBERTY AFTER GNRH AGONIST THERAPY WITH AND WITHOUT CALCIUM SUPPLEMENTATION 116
YEARS BOOK 2006 . BISFOSFONATI E ONCOLOGIA 116
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 116
Impact of the Visceral Adipose Tissue on Bone Quality in Patients with Untreated mild-to-severe Obstructive Sleep Apnoea 114
emerging drugs for the management of cancer treatment induced bone loss 114
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 114
CALCIUM SUPPLEMENTATION, OESTROGENS AND BONE DENSITY IN GNRHA TREATED PRECOCIOUS PUBERTY 113
Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle. 113
the use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemnia of malignanacy 112
The use of dichloromethylene bisphosphonate and aminobutanebisphosphonate in hypercalcemia of malignancy. 112
[Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project] 112
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 112
Transdermal estradiol in the treatment of postmenopausal bone loss. 111
EFFETTO DI UN AGONISTA DEL GNRH AD AZIONE PROLUNGATA (LEUPROLIDE ACETATO) SULLO STATO DI MINERALIZZAZIONE OSSEA IN BAMBINE CON PUBERTA' PRECOCE 110
Bone mineral density and metabolism in HIV-infected children 110
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 110
The prevention of corticosteroid-induced osteoporosis with nandrolone decantate Bone and Mineral 15, 72-81 (1991) 110
Biology and Pathophysiology of Bone Metastasis in Prostate Cancer 109
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 109
The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study 109
Transdermal Estradiol in the treatment of postmenopausale bone loss. 108
Calcium Supplementation Increases Bone Mass in GH-Deficient Prepubertal Children during GH Replacement 108
intramuscolar neridronate in postmenopausal women with low bone mineral density 106
Final peak bone mass in precocious puberty after GhRH agonist therapy with and without calcium supplementation 105
Sodium requirements regulates renal tubular reabsorption of calcium 104
Physiopatology of bone metastases 104
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 104
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiopathic hypercalcemia and with primary hyperparathyroidism 103
Valutazione della microarchitettura ossea nell'iperparatiroidismo primitivo 102
Effects of two oral doses of alendronate in the treatment of Paget’s disease of bone. 102
Intramuscular neridronate in postmenopausal women with low bone mineral density 101
HIV-infected children and bone mineral density 99
Serum 25-hydroxy vitamin D and exercise capacity in COPD. 99
Ruolo dei bisfosfonati nella terapia dell'osteoporosi 98
Osteomalacia: The missing link in the pathogenesis of Bisphosphonate-related osteonecrosis of the jaws? 98
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 98
The Effect of Bisphosphonates on Gene Expression: The GAPDH as a Housekeeping or a New Target Gene? 97
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 95
Obesità e osteoporosi 95
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiophatic hypercalciuria and primary hyperparathyroidism 94
nUOVE PROSPETTIVE NELL'UTILIZZO DEI BISFOSFONATI IN ONCOLOGIA:OLTRE LA METASTASI OSSEA 94
Effects of a 4400 km ultra-cycling non-competitive race and related training on body composition and circulating progenitors differentiation 92
Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy 92
Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteopororis fractures 92
Effects of two oral doses of alendronate in the treatment of Paget’s Disease of bone 92
longitudinal evaluation of bone mass in asthmatic children treated with ihaled beclomethasone dipropionate of cromolyn sodium 92
Treatment thresholds for osteoporosis and reimbursability criteria: perspectives associated with fracture risk-assessment tools. 92
Bone Mineral Density in Mountain, Road Cyclists and Untrained Controls: Exercise, Diet and Hormones 91
Effetto dell'alendronato sulle caratteristiche strutturali e biomeccaniche dell'osso corticale 91
Totale 12.638
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.442
article - articoli 53.413
book - libri 1.032
conference - conferenze 3.042
curatela - curatele 0
other - altro 154
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.801
Totale 120.884
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021699 0 0 0 0 153 125 25 108 112 6 132 38
2021/20221.251 96 389 6 101 48 48 14 61 39 27 122 300
2022/20232.308 218 196 274 364 227 524 12 134 240 24 73 22
2023/20241.191 53 89 131 135 170 169 59 74 7 50 159 95
2024/20253.153 188 199 113 478 170 75 182 184 461 228 213 662
2025/20263.387 640 469 763 1.356 159 0 0 0 0 0 0 0
Totale 16.960